期刊文献

The Efficacy and Safety of Cardiac Myosin Inhibitors Versus Placebo in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials 收藏

心脏肌球蛋白抑制剂与安慰剂的疗效和安全性在症状性阻塞性肥厚性心肌病患者中：随机对照试验的荟萃分析
原文求助 发布源
作者
Chidubem Ezenna (https://orcid.org/0009-0001-3988-6211) [1];Mrinal Murali Krishna [2];Meghna Joseph [3];Vinicius Pereira [4];Samia Nadeem [5];Gregory Valania [6];Andrew M. Goldsweig [7];
发布日期
2025-4
页码
52-60
DOI
10.1016/j.amjcard.2025.01.016
来源信息
The American Journal of Cardiology ISSN：0002-9149, 2025年, 241卷, 52-60页
摘要
摘要译文
Chidubem Ezenna (https://orcid.org/0009-0001-3988-6211) [1];Mrinal Murali Krishna [2];Meghna Joseph [3];Vinicius Pereira [4];Samia Nadeem [5];Gregory Valania [6];Andrew M. Goldsweig [7];. The Efficacy and Safety of Cardiac Myosin Inhibitors Versus Placebo in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials[J]. The American Journal of Cardiology, 2025,241: 52-60